Trials / Completed
CompletedNCT06568393
Effectiveness of Calisthenic Exercises in Post-Covid Syndrome
The Effect of Calisthenic Exercises on Quality of Life in Post-Covid Syndrome: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 176 (actual)
- Sponsor
- Bahçeşehir University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Post-Covid syndrome is known as the appearance of some symptoms for 12 weeks or more after Covid-19 infection, affecting the patient's quality of life. The wide range of symptoms that occur after post-Covid syndrome has led to the development of different interventions. In this study, we tried to measure changes in quality of life in people with post-covid syndrome as a result of using calisthenics with therapists and home exercise. Quality of life scale scores were compared before and after an 8-weeks exercise intervention.
Detailed description
In this study, a quantitative approach with a pre-test-post-test design was applied to compare the effect of calisthenic exercises on quality of life in individuals with post-covid syndrome in the form of a therapist-guided and home exercise programme. Participants signed an informed consent form before inclusion in the study and the details of the study were clearly explained. At baseline, age, gender, height, weight, symptoms and duration of symptoms were recorded. Quality of life data were recorded with the EQ-5D-3L questionnaire at baseline and 8 weeks after the exercise intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Calisthenic exercise | Calisthenic exercise program was included: jumping jack, burpee, mountain climber, squat thrust, squat, squat jump, split and alternate exercises. |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2024-04-01
- Completion
- 2024-04-15
- First posted
- 2024-08-23
- Last updated
- 2024-08-26
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06568393. Inclusion in this directory is not an endorsement.